Day 3 Full Agenda

Wednesday, May 6, 2026

8:30 AM

Promising Biomarkers for PTE

Introduction: Firas Kobaissy (University of Florida), Session Moderator

Alon Friedman, Dalhousie University, Halifax, Nova Scotia, Canada

Denes Agoston, Uniformed Services University, Bethesda, MD

Edward Needham, University of Cambridge, Cambridge, UK

Early-Stage Investigator (selected from abstract submissions)

10:00 AM - Break

10:15 AM

Promising Pharmacologic and Non-Pharmacologic Therapies for PTE

Introduction: Lisa Coles (University of Minnesota), Session Moderator

Pavel Klein, Mid-Atlantic Epilepsy Associates, Bethesda, MD

Jens Mikkelsen, University of Copenhagen, Denmark

Early-Stage Investigator (selected from abstract submissions)

11:25 AM

Discussion and Wrap-up: How will we prioritize therapies for early Phase Clinical Trials?

Moderator and Discussants:  Ramon Diaz-Arrastia, Pavel Klein

12:15 PM

Adjournment